Health Condition 1: O678- Other intrapartum hemorrhage
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a) Women aged 18-40 years. b) Women who underwent elective or emergency cesarean section at the study institution. c) Singleton pregnancies with no known placental or uterine abnormalities. d) Women who received either IV calcium chloride with oxytocin (group 1) or only oxytocin (group 2) as part of routine clinical management.
Exclusion criteria
Exclusion criteria: a) Women with known allergies or contraindications to calcium chloride. b) Women with pre-existing cardiac arrhythmias or significant cardiovascular disease. c) Women with pre-existing coagulopathies or those who are on anticoagulant therapy. d) Women with uterine anomalies, placenta previa, or other conditions that may confound blood loss. e) Women who had a hysterectomy or other major surgical interventions during the cesarean.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total blood loss during cesarean section as measured by the volume of blood collected in suction containers and the weight of surgical sponges (considering 1 g of weight = 1 mL of blood).Timepoint: 18 monnths | — |
Secondary
| Measure | Time frame |
|---|---|
| Need for blood transfusion due to excessive blood loss (if applicable). Timepoint: 18 months;Uterine tone post-delivery (evaluated by the obstetrician). Timepoint: 18 months;Incidence of uterine atony, requiring additional uterotonic drugs. Timepoint: 18 months;Maternal complications: Hypotension, arrhythmias, or hypercalcemia. Timepoint: 18 months;Length of hospital stay and recovery outcomes. Timepoint: 18 months | — |
Countries
India
Contacts
AIIMS Kalyani